Elanco executive appointed as Neurizon's Board Observer

Contributed by: PR Newswire

Tags

Neurizon-Therapeutics

More Like This

PR Newswire associated0

Neurizon Enters into Global License with Elanco to Accelerate Commercialisation of NUZ-001

PR Newswire associated0

FDA Lifts Clinical Hold on NUZ-001

PR Newswire associated0

Neurizon Therapeutics Receives Positive Opinion on Orphan Medicinal Product Designation for NUZ-001 in Europe

PR Newswire associated0

Neurizon Files IND Application to Support HEALEY ALS Platform Trial

PR Newswire associated0

Neurizon's NUZ-001 Reduces Aggregation of Key ALS Disease Target TDP-43 in Preclinical Study

EQT Life Sciences invests in Asceneuron, a neurodegeneration therapeutics company, as part of USD 100 million Series C financing round

Business Wire logo

Neumirna Therapeutics Appoints Ellen K. Donnelly as Chief Executive Officer

PR Newswire associated0

Alkermes Announces Appointment of Nancy S. Lurker to Board of Directors